EUVIMEDOpdag EUVIMED
Crossref

The mechanism of IL‐13 targeting IL‐13Rα2 in regulating oral mucosal FBs through PI3K/AKT/mTOR

Liping Wang iD, Jingyi Cheng, Junhui Huang, Ting Xiao, Zhangui Tang iD

Oral Diseases · 2024

DOI: 10.1111/odi.14760 ↗

At a glance

Journal article in Oral Diseases, 2024. Written by Liping Wang and 4 co-authors. Institution: Hunan Key Laboratory of Oral Health Research & Hunan 3D Printing Engineering Research Center of Oral Care & Academician Workstation for Oral-maxilofa…. Major MEDLINE topics: TOR Serine-Threonine Kinases, Interleukin-13, Proto-Oncogene Proteins c-akt, Mouth Mucosa. Cited 3 times so far (Crossref); 44 references. Funded by: National Natural Science Foundation of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

The objective of this investigation was to examine the presence of interleukin (IL)‐13 and its receptor IL‐13Rα2 in the tissues of oral submucous fibrosis (OSF), investigate their biological functions, and explore the underlying mechanisms involved in the development of OSF. Materials and Methods The expression of IL‐13 and IL‐13Rα2 in the oral mucosa of patients with OSF and normal individuals was determined through immunohistochemistry and reverse transcription–quantitative polymerase chain reaction (RT–qPCR). Primary fibroblasts (FBs) were extracted through enzymatic digestion and then cultured. Immunofluorescence was employed to identify the FB cultures and the location of IL‐13Rα2. The effects of IL‐13/IL‐13Rα2/PI3K/AKT/mTOR on the migration, proliferation, and secretion of fiber‐related proteins of FBs were explored via the wound healing assay, CCK‐8 assay, EDU assay, and RT–qPCR. The impact of IL‐13Rα2 silencing and PI3K/AKT inhibition on the effect of IL‐13 on FBs was analyzed by RT–qPCR and Western blotting.

Results

IL‐13 and IL‐13Rα2 were highly expressed in OSF. Primary FBs were successfully extracted and cultured. IL‐13Rα2 was found to be localized in myofibroblasts. IL‐13 promoted the proliferation, migration, and secretion of fibril‐associated proteins in FBs. The proliferation, migration, and secretion of fibril‐associated proteins of FBs were decreased following IL‐13Rα2 silencing and inhibition of the PI3K/AKT/mTOR pathway.

Conclusion

IL‐13 may promote the proliferation, migration, and secretion of fiber‐related proteins of FBs through the PI3K/AKT/mTOR pathway by targeting IL‐13Rα2.

Subjects

MeSH terms (MEDLINE)

TOR Serine-Threonine KinasesInterleukin-13Proto-Oncogene Proteins c-aktMouth MucosaPhosphatidylinositol 3-KinasesInterleukin-13 Receptor alpha2 SubunitFibroblastsCell MovementCell ProliferationOral Submucous FibrosisHumansSignal TransductionCells, CulturedMaleAdult

Author keywords

IL‐13IL‐13Rα2OSFPI3K/AKT/mTORfibroblastsphosphorylation

Substances

TOR Serine-Threonine KinasesInterleukin-13Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesInterleukin-13 Receptor alpha2 SubunitMTOR protein, humanIL13 protein, human

Authors and institutions

  • Hunan Key Laboratory of Oral Health Research & Hunan 3D Printing Engineering Research Center of Oral Care & Academician Workstation for Oral-maxilofacial and Regenerative Medicine & Hunan Clinical Research Center of Ora…

ORCID profiles: Liping Wang, Zhangui Tang

Funding

  • National Natural Science Foundation of China

Cite

APA

Wang, L., Cheng, J., Huang, J., Xiao, T., & Tang, Z. (2024). The mechanism of IL‐13 targeting IL‐13Rα2 in regulating oral mucosal FBs through PI3K/AKT/mTOR. Oral Diseases. https://doi.org/10.1111/odi.14760

Vancouver

Wang L, Cheng J, Huang J, Xiao T, Tang Z. The mechanism of IL‐13 targeting IL‐13Rα2 in regulating oral mucosal FBs through PI3K/AKT/mTOR. Oral Diseases. 2024. doi:10.1111/odi.14760

BibTeX
@article{Wang2024,
  author = {Wang, Liping and Cheng, Jingyi and Huang, Junhui and Xiao, Ting and Tang, Zhangui},
  title = {The mechanism of IL‐13 targeting IL‐13Rα2 in regulating oral mucosal FBs through PI3K/AKT/mTOR},
  journal = {Oral Diseases},
  year = {2024},
  doi = {10.1111/odi.14760}
}
Start for free →